170 related articles for article (PubMed ID: 7102699)
1. Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir.
Kern ER; Richards JT; Glasgow LA; Overall JC; de Miranda P
Am J Med; 1982 Jul; 73(1A):125-31. PubMed ID: 7102699
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
Collins P; Oliver NM
Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
Field HJ; De Clercq E
J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
Machida H; Ikeda T; Ashida N
Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir treatment of experimental genital herpes simplex virus infections.
Kern ER
Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
[TBL] [Abstract][Full Text] [Related]
8. Ganglionic herpes simplex and systemic acyclovir.
Pavan-Langston D; Park NH; Hettinger M
Arch Ophthalmol; 1981 Aug; 99(8):1417-9. PubMed ID: 6266375
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.
Sicher SE; Oh JO
Antimicrob Agents Chemother; 1981 Oct; 20(4):503-7. PubMed ID: 6282195
[TBL] [Abstract][Full Text] [Related]
12. Late recurrence of herpes simplex virus meningoencephalitis in two infants.
Mandyla H; Anagnostakis D; Koutsovitis P; Siahanidou T; Youroukos S
Eur J Pediatr; 2001 Dec; 160(12):732-5. PubMed ID: 11795682
[TBL] [Abstract][Full Text] [Related]
13. Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.
Biron KK; Noblin JE; de Miranda P; Elion GB
Antimicrob Agents Chemother; 1982 Jan; 21(1):44-50. PubMed ID: 7081975
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.
Fonseca-Aten M; Messina AF; Jafri HS; Sánchez PJ
Pediatrics; 2005 Mar; 115(3):804-9. PubMed ID: 15741392
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
Tyler KL
Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
[TBL] [Abstract][Full Text] [Related]
16. Preventive and curative effects of acyclovir on central nervous system infections in hamsters inoculated with herpes simplex virus.
van Ekdom LT; Versteeg J
Am J Med; 1982 Jul; 73(1A):161-4. PubMed ID: 6285708
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir treatment of disseminated herpes simplex virus type 2 infection in weanling mice: alteration of mortality and pathogenesis.
Kern ER; Richards JT; Overall JC
Antiviral Res; 1986 Jul; 6(4):189-95. PubMed ID: 2427021
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
Sutton D; Boyd MR
Antimicrob Agents Chemother; 1993 Apr; 37(4):642-5. PubMed ID: 8388195
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir treatment of experimentally induced herpes simplex virus encephalitis: monitoring the changes in immunologic NO synthase expression and viral load within brain tissue of SJL mice.
Haas J; Meyding-Lamadé U; Fäth A; Stingele K; Storch-Hagenlocher B; Wildemann B
Neurosci Lett; 1999 Apr; 264(1-3):129-32. PubMed ID: 10320031
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
